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ABSTRACT Vancomycin-resistant Enterococcus faecium (VREfm) is a major cause of
nosocomial infection and is categorized as high priority by the World Health Organi-
zation global priority list of antibiotic-resistant bacteria. In the past, livestock have
been proposed as a putative reservoir for drug-resistant E. faecium strains that infect
humans, and isolates of the same lineage have been found in both reservoirs. We
undertook cross-sectional surveys to isolate E. faecium (including VREfm) from live-
stock farms, retail meat, and wastewater treatment plants in the United Kingdom.
More than 600 isolates from these sources were sequenced, and their relatedness
and antibiotic resistance genes were compared with genomes of almost 800 E. fae-
cium isolates from patients with bloodstream infection in the United Kingdom and
Ireland. E. faecium was isolated from 28/29 farms; none of these isolates were
VREfm, suggesting a decrease in VREfm prevalence since the last UK livestock survey
in 2003. However, VREfm was isolated from 1% to 2% of retail meat products and
was ubiquitous in wastewater treatment plants. Phylogenetic comparison demon-
strated that the majority of human and livestock-related isolates were genetically
distinct, although pig isolates from three farms were more genetically related to hu-
man isolates from 2001 to 2004 (minimum of 50 single-nucleotide polymorphisms
[SNPs]). Analysis of accessory (variable) genes added further evidence for distinct
niche adaptation. An analysis of acquired antibiotic resistance genes and their vari-
ants revealed limited sharing between humans and livestock. Our ﬁndings indicate
that the majority of E. faecium strains infecting patients are largely distinct from
those from livestock in this setting, with limited sharing of strains and resistance
genes.
IMPORTANCE The rise in rates of human infection caused by vancomycin-resistant
Enterococcus faecium (VREfm) strains between 1988 to the 2000s in Europe was sug-
gested to be associated with acquisition from livestock. As a result, the European
Union banned the use of the glycopeptide drug avoparcin as a growth promoter in
livestock feed. While some studies reported a decrease in VREfm in livestock, others
reported no reduction. Here, we report the ﬁrst livestock VREfm prevalence survey in
the UK since 2003 and the ﬁrst large-scale study using whole-genome sequencing to
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investigate the relationship between E. faecium strains in livestock and humans. We
found a low prevalence of VREfm in retail meat and limited evidence for recent
sharing of strains between livestock and humans with bloodstream infection. There
was evidence for limited sharing of genes encoding antibiotic resistance between
these reservoirs, a ﬁnding which requires further research.
KEYWORDS vancomycin-resistant, Enterococcus faecium, One Health, livestock,
genome sequencing, vancomycin resistant
Enterococcus faecium is a major cause of nosocomial infection in immunocompro-mised and critically ill patients (1) and is a globally distributed cause of disease (2).
Vancomycin-resistant E. faecium (VREfm) was ﬁrst reported in 1988 (3, 4), followed
during the 1990s by a rapid increase in rates of VREfm infections in hospitals in the
United Kingdom (5). It was proposed that humans may have acquired VREfm or
vancomycin resistance genes from livestock, linked to the use in Europe of avoparcin
(an analog of vancomycin) as a growth promoter (6). Avoparcin was subsequently
banned in Europe in 1997, after which many studies reported a decrease in VREfm in
livestock (7). However, VREfm never completely disappeared from livestock (8), and one
study even reported increased VREfm prevalence (9). The last study of VREfm in
livestock to be conducted in the United Kingdom was in 2003, and it reported the
isolation of VREfm in 27/33 poultry and 4/14 pig farms (10). Despite the ban on
avoparcin use, rates of VREfm infections in humans have remained high, and the World
Health Organization (WHO) global priority list of antibiotic-resistant bacteria has re-
cently categorized VREfm as high priority (11). This reﬂects limited treatment options
and higher mortality and health care costs for infections by vancomycin-resistant versus
vancomycin-susceptible enterococci (12–16).
The failure to control VREfm infections in the United Kingdom is in stark contrast to
the success with methicillin-resistant Staphylococcus aureus and Clostridium difﬁcile
infections (17). Preventing infection depends on deﬁning and controlling the sources
from which bacteria are acquired. While patients and the hospital environment have
been implicated as important sources of VREfm infections (18, 19), strategies to more
generally tackle antibiotic resistance have highlighted the need to identify and contain
additional reservoirs of antimicrobial resistance (20). Whole-genome sequencing has
been shown to be a highly discriminatory technique for E. faecium and other bacterial
species. However, to date, only a single whole-genome sequencing study limited to 10
European livestock isolates has compared E. faecium isolates from livestock to those
from other reservoirs (21). This landmark genomic study found that isolates from
livestock and human infections formed distinct clades, conﬁrming earlier, larger-scale
studies that used more limited typing schemes (22). Further sequencing of hundreds of
isolates from human infections has conﬁrmed that these isolates predominantly belong
to a hospital-associated clade (18, 23). However, human and livestock isolates belong-
ing to the same sequence types (STs) are well described (24, 25), although detailed
genomic studies to deﬁne relatedness between human and livestock isolates in the
same lineage are lacking.
Here, we present the ﬁndings of the ﬁrst large-scale whole-genome sequencing
study of E. faecium from livestock and clinical isolates and the most comprehensive
analysis to date of E. faecium from different reservoirs. We focus on two categories of
analyses, ﬁrst comparing the core genomes of E. faecium isolates from different
reservoirs to determine phylogenetic relatedness and second, deﬁning the extent to
which genes and genetic elements in the accessory genome (including those encoding
drug resistance) were shared.
RESULTS
Isolation of E. faecium from farms and retail meat. We isolated E. faecium from
livestock during a cross-sectional survey of 29 farms (ten cattle, ten pig, and nine
poultry) in the East of England (UK), between 2014 and 2015 (Fig. S1A). We cultured 142
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samples (136 pooled fecal/cecal samples [35 from cattle, 51 from pigs, and 50 from
poultry], 2 porcine cecal samples from necropsy, and 4 fresh farm runoffs) for E. faecium
on culture media that was selective for enterococci, ampicillin-resistant enterococci (a
surrogate marker for hospital-associated E. faecium lineages; see reference 26), or
VREfm after enrichment. Ampicillin-susceptible and -resistant E. faecium isolates were
isolated from 28 and 19 farms, respectively, but no samples grew VREfm. Despite these
negative results, people could still be exposed to VREfm in meat produced elsewhere.
To investigate this, we undertook two independent cross-sectional surveys of prepack-
aged fresh meat. The ﬁrst tested 103 products labeled as UK farm origin from 28
high-street supermarkets from ﬁve regions of the United Kingdom in February to March
2015. The second tested 97 products purchased in 11 high-street supermarkets in
Cambridge, East of England, in April 2015. These originated from multiple countries
although the majority (69/97; 71%) were from the United Kingdom (Table S1). Three
chicken products from the United Kingdom were positive for VREfm. Two (2%) were
from the United Kingdom-wide survey, and one was (1%) from the Cambridge survey
(corresponding to 3.7% of all chicken products), and they originated from two super-
market chains in three different store locations.
Phylogenetic description of E. faecium from farms and retail meat. We se-
quenced the three VREfm meat isolates and 253 E. faecium isolates from livestock (52%
ampicillin resistant), from which 94 multilocus sequence types (STs) were derived,
including 35 novel STs (Table S2). The three meat isolates all belonged to the same
novel ST, sequence type 1249 (ST1249), which was not represented in our livestock
collection. A maximum-likelihood phylogeny based on single-nucleotide polymor-
phisms (SNPs) in the core genes of the 256 isolates demonstrated two distinct lineages,
containing 249 (97%) and seven (3%) isolates, respectively (Fig. S1B). E. faecium isolates
from each livestock species were genetically diverse and distributed across the phy-
logeny. Clustering was observed for isolates from the same species, together with
relatedness of isolates from different species (particularly between chickens and turkeys
and between pigs and cattle). The three meat isolates resided on their own branch in
the predominant lineage and differed from each other by 27 to 61 SNPs, compared with
a SNP difference of 2,390 from the closest livestock isolate (from a turkey).
Phylogenetic relatedness of E. faecium isolated from patients with blood-
stream infection and nonhuman sources. We compared the genetic relatedness of
the 256 livestock/meat E. faecium genomes with 782 E. faecium genomes associated
with bloodstream infections in patients in the United Kingdom (362 from hospitals in
the East of England), 383 E. faecium isolates isolated from 20 municipal wastewater
treatment plants (Fig. S1A) in the East of England, 11 NCTC strains, and 10 other
reference strains. A maximum-likelihood phylogenetic tree of the 1,442 isolate ge-
nomes based on core gene SNPs conﬁrmed previous observations that the E. faecium
population is divided into two major lineages (referred to previously as clade A
(comprising hospital-associated A1 and animal-associated A2) and clade B (community-
associated); see reference 21) (Fig. 1). The population structure was further categorized
using Bayesian analysis, which identiﬁed ten Bayesian analysis of population structure
(BAPS) groups (Fig. 1). Of these, BAPS3 (n  39 isolates), BAPS7 (n  18), and BAPS10
(n  3) resided in clade B; BAPS1 (n  529), BAPS2 (n  138), BAPS6 (n  117), and
BAPS9 (n  262) in clade A1; BAPS4 (n  117) and BAPS8 (n  108) in clade A2; and
BAPS5 (n  111) was intermediate between clade A1 and A2. BAPS groups were
paraphyletic (located in two different positions on the tree), particularly BAPS5 and the
clade A1 BAPS groups, which is likely to be due to the highly dynamic nature of the E.
faecium genome and recombination between different lineages. There was notable
segregation of BAPS groups associated with livestock (e.g., BAPS4 and BAPS8; 75%
livestock) versus human invasive isolates (e.g., BAPS1, BAPS2, BAPS6, and BAPS9; 96%
human invasive isolates) despite selecting for ampicillin-resistant livestock isolates,
which we predicted would enrich for hospital-associated lineages. In contrast, we noted
extensive mixing between isolates from wastewater and human disease and between
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November/December 2018 Volume 9 Issue 6 e01780-18 mbio.asm.org 3
 o
n
 N
ovem
ber 14, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
those from wastewater and livestock (Fig. 1). The wastewater isolates originated from
multiple treatment plants in all three clades, with all 20 treatment plants represented
in clade A1. Of note, one BAPS group in clade A1 (BAPS6) contained predominantly
wastewater isolates (91%, mostly ST80 [84%]), which were collected from 17 different
wastewater treatment plants. This may either be a dominant lineage in the environ-
ment or, more likely, may represent a recent emergence of a lineage. The three VREfm
meat isolates belonged to BAPS8 and resided within a poultry lineage.
Next, we deﬁned the degree of genetic relatedness between 1,144 deduplicated
livestock, human, and wastewater genomes in a pairwise comparison of SNPs after
mapping to BAPS group-speciﬁc references. Deduplication was performed by removing
isolates within 0 to 2 SNPs of each other from the same farm, wastewater plant, or
hospital. Within the animal-associated BAPS groups (BAPS4 and BAPS8) and BAPS5, the
most closely related isolate pair from livestock and humans differed by 129 SNPs,
which, given a mutation rate of 7 SNPs/genome/year (18), equates to approximately
18 years of evolution. However, the most closely related isolate pair in the hospital-
associated BAPS groups (comprising BAPS1, BAPS2, BAPS6, and BAPS9) was 40 SNPs
apart. Based on the time between isolation and an estimated mutation rate of 7
SNPs/genome/year, 6 of the 7 pig isolates (from three different farms) residing in clade
A1 after deduplication were related to 17 human isolates (50 to 91 SNPs different, with
10 to 13 years between sampling) from across the United Kingdom and Northern
Ireland isolated between 2001 and 2004. No isolates from cattle, chickens, or turkeys
were closely related to the human isolates. The six pig isolates represented 10% of the
deduplicated pig collection (6/60), but 5/6 of these pig isolates were ampicillin resistant
and thus had been enriched for by the selection process. We also identiﬁed closely
related isolate pairs from livestock and wastewater and from humans and wastewater
(minimum 8- and 2-SNP difference, respectively) suggesting sharing within approxi-
mately the last year between these reservoirs.
Genetic relatedness of E. faecium isolates within and between livestock spe-
cies. To address the relatedness of E. faecium strains within and between livestock
FIG 1 Maximum likelihood tree based on SNPs in the genes core to the 1,442 E. faecium isolates in the collection. Colored rings from inner
to outer indicate isolate source, BAPS group, phenotypic resistance to ampicillin (black, resistant; white, susceptible/intermediate), and
phenotypic resistance to vancomycin (black, resistant; white, susceptible). Outermost ring indicates the clades, with the gaps in Clade A1
corresponding to BAPS5.
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species and farms, a network was created based on a pairwise comparison, in which
pairs of livestock isolates were classiﬁed as genetically related if they were less than or
equal to seven SNPs different (equivalent to approximately 1 year of evolution). There
was no evidence of E. faecium relatedness between different livestock species, with the
exception of E. faecium relatedness between chickens and turkeys (Fig. 2A). In contrast,
there was evidence for relatedness of E. faecium strains within livestock species
(chickens, turkeys, and pigs, but not cattle) across different farms. Reanalysis using a
35-SNP cutoff (an estimated 5 years since most recent common ancestor) extended
these links and identiﬁed links between farms and wastewater isolates (Fig. 2B). There
was no evidence for sharing between cattle or pigs versus other livestock species using
this cutoff, with minimums of 477 and 292 SNPs identiﬁed, respectively.
Comparison of accessory gene content of E. faecium isolates from human and
nonhuman sources. We then evaluated and compared the variable (accessory) ge-
nome of the 1,144 deduplicated study isolates. On principal component analysis,
principal component 1 (PC1) and PC2 predominantly segregated the accessory genome
into the three clades (A1, A2, and B), with BAPS5 clustering with A2 (Fig. 3A and B).
Twenty-ﬁve isolates were positioned between the animal and hospital-associated
clades, suggesting sharing of accessory genes. Similar to the core gene phylogeny, 12
human isolates clustered with clade A2, six livestock with clade A1, and 12 human and
nine livestock isolates with clade B. Wastewater isolates were distributed throughout
the plot, consistent with this being a representation of both livestock and human
lineages. PC3 and PC4 predominantly segregated BAPS9 and BAPS6 (Fig. 3C and D),
indicating lineage-speciﬁc traits within the hospital-associated clade. Genes associated
with BAPS9 included phage-related genes, while genes associated with BAPS6 included
transposase and phosphotransferase system (PTS) genes (Table S3), the latter being a
recognized marker of adaptation (21).
We also performed a genome-wide association study on the 849 deduplicated
livestock and human genomes to detect accessory genes that were signiﬁcantly
associated with livestock or human isolates. Thirty-two genes were signiﬁcantly asso-
ciated with human isolates, including a lactose operon and a trimethoprim resistance
gene (labelled dhfr_2 in Figure 4, identical to dfrG using BLAST). Fifty-two genes were
signiﬁcantly associated with livestock isolates, including a copper resistance operon
(containing tcrB) predominantly found in pigs and a streptogramin resistance gene
(vatD) found exclusively in turkeys (26% of turkeys) (Fig. 4 and Table S4).
Antibiotic resistance genes in E. faecium isolates from human and nonhuman
sources. We then undertook an analysis of accessory genes encoding antibiotic
resistance across the 1,144 deduplicated isolates in the collection. Twenty-six out of
FIG 2 Network analysis of E. faecium isolates from farms and wastewater treatment plants. Lines are drawn between farms/plants sharing isolates less than
seven SNPs (A) or 35 SNPs (B) apart, indicating approximately 1 and 5 years of evolution, respectively. Lines only show binary links between farms, with arbitrary
line lengths. Blue square, wastewater treatment plant; pink circle, pig farm; light blue circle, cattle farm; black circle, turkey farm; yellow circle, chicken farm.
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44 genes were identiﬁed in both human and livestock isolates (Fig. 5A). In many cases,
these predominated in one reservoir or the other, but there were notable examples
where genes were frequent in both, including macrolide and aminoglycoside, and, to
a lesser extent, tetracycline resistance genes, likely reﬂecting the prominent roles these
antibiotics have in both human and veterinary medicine (Fig. 5B; note that the
proportions have the limitation that the sampling strategy was different for different
reservoirs). Strikingly, several genes conferring resistance to antibiotics or metals used
predominantly or exclusively in animals were identiﬁed at low levels in human invasive
isolates (0.7%, 0.4%, and 1.1% carried bcrA [encoding bacitracin resistance], tcrB, and
cueO [encoding copper resistance], respectively). The human isolates harboring these
genes belonged to clade A1 (n 6), clade B (n 4), and BAPS5 (n 2). Two genes
coding for an ABC-type transporter associated with resistance to the antiprotozoal
agent narasin, used in poultry (27), were common in chicken and turkey isolates (95%)
and found at a very low level in human invasive isolates (1.4% to 2.3%; predominantly
from clade A1 [90% to 94%]). Additionally, we identiﬁed optrA, a gene associated with
linezolid and phenicol resistance (28), in one human isolate (clade A1) and six pig
isolates (BAPS5, n 5; clade A1, n 1). optrA was also detected in one isolate from
wastewater.
Next, we evaluated the degree to which the genes from the two sources were
related by constructing phylogenetic trees for each antibiotic resistance gene (Fig. 6).
All 26 genes had evidence of gene sharing between human and livestock isolates based
on 100% gene sequence identity, although the proportion of isolates involved was
highly variable. The distribution of thirteen genes conferring resistance to antibiotics
that are used in livestock and also important for human health (29) is shown in Table S5
(note that the proportions have the limitation of the sampling strategy). In most cases,
FIG 3 Principal component analysis based on the presence/absence of E. faecium accessory genes across the study collection. Panels A and B show principal
component (PC) 1 (x axis) against PC2 (y axis) labeled by BAPS group (A) or isolate source (B). Panels C and D show PC3 (x axis) against PC4 (y axis) labeled
by BAPS group (C) or isolate source (D). Principal components 1, 2, 3, and 4 explain 46%, 5%, 3%, and 2% of the variation within the accessory genome,
respectively.
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FIG 4 Genome-wide association study to detect genes that were overrepresented in E. faecium isolates from livestock and humans. (Left)
maximum likelihood tree based on SNPs in the core genes of farm animal and human invasive isolates (n  849). First two columns show
the source species (red, human; pink, pig; light blue, cattle; black, turkey; yellow, chicken) and BAPS group (dark blue, BAPS1; gray, BAPS2;
(Continued on next page)
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the proportion of human and livestock isolates that shared genes was very low.
Exceptions included aph3=-III (present in 69.1% of human and 19.5% livestock isolates)
and tetL (present in 13.3% of human and 28.3% livestock isolates).
Two resistance genes (encoding resistance to the aminoglycoside-related antibiotic
spectinomycin [spw] and to tetracycline [tetM]) were further evaluated to determine
whether sharing between reservoirs was associated with a speciﬁc mobile element
(Table S6). These genes were selected because they were present in a high proportion
of livestock isolates and their prevalence in livestock exceeded that in humans. Two
variants of spw were shared by one human/one livestock and four human/88 livestock
isolates, respectively. The gene was located in a 26.2-kb or 9.9-kb to 12.4-kb region
shared by human and livestock isolates (0 to 1 SNPs different, equating to less than two
months of evolution based on the seven SNP/core genome/year cutoff) in 1/1 and 3/4
human isolates, respectively (Fig. S2). In the remaining human isolate, the gene was
located in a shared 3-kb region located adjacent to the contig end, which contained a
gene encoding a hypothetical protein, spw, apt, and aadE2. Five variants of tetM were
shared, three of which were at a low prevalence (3.1%) in both reservoirs and not
analyzed further. The remaining two variants were shared by one human and 16
livestock and by 11 and 38 livestock isolates, respectively. The gene was located in 6.7-
to 21.3-kb regions shared by human and livestock isolates (0 to 1 SNPs difference),
which contained one or more conjugative transposon genes in 1/1 and 10/11 human
isolates, respectively (Fig. S2).
Finally, we determined the genetic context of the vancomycin resistance genes in
the three meat VREfm isolates and compared it to that of the non-deduplicated full
isolate collection (n  1,442). The whole vanA Tn1546 transposon was identiﬁed in
FIG 4 Legend (Continued)
red, BAPS3; light green, BAPS4; pink, BAPS5; orange, BAPS6; yellow, BAPS7; dark green, BAPS8; light blue, BAPS9). Further columns are based
on the accessory genome and show the presence (red) or absence (white) of genes strongly associated with humans (A) or animals (B).
Columns are ordered based on the pattern of presence and absence. Scale bars indicate 30,000 SNPs.
FIG 5 Genetic analysis of antibiotic resistance genes in E. faecium. (A) Venn diagram showing antibiotic resistance genes identiﬁed in each reservoir. (B) Bubble
graph showing the prevalence of genes in isolates from humans versus animals. Lower graph shows an expanded view of low-prevalence genes from the upper
graph. Size of the bubble represents the number of isolates that the gene was identiﬁed in. Bubbles are colored by antibiotic class.
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single contigs of between 14.6 and 29.9 kb in the three meat isolates, which contrasts
with the vanA transposons from the human isolates, which were often present on
multiple contigs due to interruption by IS elements. In all three meat vanA contigs, the
Tn1546 transposon was ﬂanked by a truncated streptomycin resistance str gene, and
FIG 6 Comparison of antibiotic resistance gene variants in E. faecium isolates from humans, livestock and wastewater. Each ﬁgure section shows a phylogenetic
tree of an antibiotic resistance gene based on SNPs. Pie charts show the source of the isolates in which each gene variant was found (see key for colors), and
the size of the pie chart indicates the number of isolates that variant was identiﬁed in (see key).
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the largest contig also contained an ermB gene. The contig sequences matched 99%
to pVEF4 (accession number FN424376), a plasmid isolated from a Norwegian poultry
farm previously exposed to avoparcin (30). The isolate with the best match to pVEF4
was sequenced using PacBio technology, and a circularized plasmid of 45.7 kb (termed
VREN1260_c3 here) was found to be highly similar to pVEF4 (99% identity over 96%
of the sequence). Mapping reads of the whole collection against VREN1260_c3
showed that the other two meat isolates covered 97.9% of the sequence, while
isolates from other reservoirs covered between 12.8% to 71.5%, suggesting that this
plasmid has not spread to human invasive VREfm isolates in the UK. Importantly, in
the human isolates there was no evidence of reads mapping to the sequences
immediately upstream or downstream of the vanA transposon, suggesting that the
vanA element was not shared between the human and meat isolates as part of a
smaller transposable element. All three meat isolates also mapped to the ABC-type
transporter genes present in VREN1260_c3, associated with narasin resistance, in
addition to the ermB gene.
DISCUSSION
This represents the ﬁrst survey of VREfm conducted in British livestock since 2003,
when a study in England and Wales reported the isolation of VREfm from 27/33 poultry
and 4/14 pig farms (10). No VREfm was isolated from livestock in this study, suggesting
that the rates of VREfm in livestock have fallen since the last survey in 2003. This is likely
to be related to the ban in 1997 on the use of avoparcin as a growth promoter (7),
3 years after the ﬁrst description of VREfm in British livestock (31).
One possible route of E. faecium and antibiotic resistance gene transfer from
livestock to humans is through the food chain via meat. Surveys of retail meat drawn
from producers over a wide geographic region demonstrated that low-level exposure
to VREfm in 1% to 2% of uncooked meat products (3.7% of chicken meat) represents
an ongoing potential zoonotic risk. All three products positive for VREfm were from the
United Kingdom, and the E. faecium strains belonged to an animal-associated lineage,
suggesting that VREfm has not been eradicated entirely from livestock, similar to the
experience of other countries. However, the low frequency, combined with the bacte-
ricidal effect of heat during cooking, means that the risk of human exposure to VREfm
in cooked food is likely to be very low. Indeed, we found no evidence that the vanA
transposon or plasmid from the meat isolates was shared with any of the human or
wastewater VREfm isolates. Although the number of VREfm isolates from meat was
small, recovery of the same strain from chicken meat from two different supermarket
chains at two different time points is consistent with the presence of a speciﬁc lineage
of VREfm associated with poultry. The vanA plasmid was highly homologous to a
plasmid (pVEF4) isolated in Norwegian poultry in 1998, with a pVEF4-like plasmid also
reported very recently from Danish chicken meat (32) suggesting its widespread
geographic and temporal dissemination. Possible reasons for persistence of vancomy-
cin resistance genes 18 years after the ban of avoparcin in this plasmid include
coselection by other antimicrobials used in livestock, such as macrolides or narasin, as
suggested by the presence of ermB and ABC-type transporter genes (27, 33), and
presence of a toxin-antitoxin system. Other possibilities include persistence in the farm
or abattoir environment, with carryover of VREfm between successive ﬂocks due to
environmental survival and inadequate cleaning (10, 34), or possibly through avian
carriage and transfer. Overall, our ﬁndings support the continued ban of avoparcin to
limit VREfm spread within the livestock population and the potential spillover into
human community carriage. While we cannot exclude the possibility of historical
transfer of vancomycin resistance genes between animals and humans, we demon-
strate that livestock is unlikely to be playing a signiﬁcant role in the persistence of
vancomycin resistance genes in human invasive isolates in the United Kingdom, where
the situation now resembles that of the United States, where avoparcin was never used
in agriculture.
We found largely host-adapted populations of E. faecium using phylogenetic anal-
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ysis of the core genome, with the majority of livestock isolates from the United
Kingdom located in lineages that were distinct from the hospital-associated clade.
Despite this, there was evidence of limited overlap between isolates of livestock and
hospital origin. Isolates causing human infection were found in the livestock-associated
clade A2, as previously reported (21), although they were not closely related (minimum
distance, 129 SNPs). Surprisingly, some livestock isolates resided in the previously
considered human commensal clade B, and, more importantly, pig isolates resided in
the hospital-associated clade A1. Previous genomic evidence of livestock isolates in this
clade is lacking and limited to older typing techniques, which detected ST18 in the pig
environment (24, 25). Here, porcine E. faecium (ST17, ST18, ST262, and ST947) was
related to human infection isolates from 2001 to 2004, indicating potential human-to-
pig or pig-to-human transmission more than a decade ago. The pig isolates were
predominantly ampicillin resistant and had typical adaptations to the porcine environ-
ment, such as copper resistance genes.
Further evidence for distinct populations was provided by two different compari-
sons of the accessory genome, ﬁndings from which were consistent with a divergent
evolutionary history and host adaptation for human- and animal-derived isolates. These
analyses identiﬁed overrepresentation of a copper resistance operon in isolates from
pigs and an exclusive association between a streptogramin resistance gene (vatD) and
turkey isolates, which is consistent with the use of copper as a growth promoter in pigs
(35) and historical use of virginiamycin as a growth promoter in poultry until its ban in
1998 (36).
Our analysis of mobile genes that encode resistance to antibiotics used in humans
and livestock demonstrated that 26 different genes were present in human and live-
stock isolates. This indicates that such genes are ubiquitous but does not distinguish
between frequent human-animal exchange and independent, parallel acquisition of
resistance in the two groups. In-depth analysis of resistance genes to thirteen antibi-
otics used in humans and animals showed that the proportion of human and livestock
isolates that shared the same gene was very low. Furthermore, evaluation of resistance
to agents used predominantly or exclusively in animals (such as bacitracin or narasin
and copper, respectively) demonstrated that such genes were present at low levels in
human invasive isolates. This would argue for limited exchange of resistance genes
between the two groups or, alternatively, lack of persistence due to absence of
selective pressure. Important exceptions were the presence of genetically identical
genes in human- and animal-derived isolates that encoded resistance to antibiotics
commonly used in both human and veterinary medicine, such as tetracyclines, mac-
rolides, and aminoglycosides. This is of concern, as aminoglycosides and macrolides are
included in the WHO list of critically important antibiotics and tetracyclines in the list
of highly important antibiotics (37).
Finally, we identiﬁed closely related isolates from farms of the same livestock species
(with the exception of cattle) and from chickens and turkeys. While the farms were not
colocated, one possible explanation is that chicken, turkey, and pig farms each be-
longed to the same company. Additionally, pigs from the different farms were likely to
have shared a great-great-grandmother, with the potential for vertical transmission. In
contrast, the cattle farms, which did not share strains, were owned by independent
farmers. This suggests that the E. faecium population in livestock is highly mobile
between farms, a ﬁnding of note for farmers and veterinary agencies.
A limitation of our study is the lack of human carriage isolates. Municipal wastewater
is considered to represent pooled human gut bacterial populations (38). We found that
both human- and animal-derived E. faecium isolates were represented in samples taken
from wastewater plants, with farm and wastewater isolates separated by as few as
8 SNPs. There was no known discharge of farm efﬂuent into the wastewater plants at
the time of sampling, which suggests that clade A2 (animal-associated) isolates may be
carried by healthy humans. Human carriage studies will be required to provide more
conclusive evidence.
In conclusion, this study represents the ﬁrst large-scale whole-genome sequencing
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study investigating the relationship between livestock and human infections. The
results of this study conﬁrm previous ﬁndings (21, 22) that E. faecium strains from
livestock are not the cause of signiﬁcant human disease but provides evidence for
limited sharing of hospital-associated strains with pigs and of resistance genes with
livestock species. Further studies are needed to determine whether our ﬁndings are
relevant to different settings globally, where proximity to livestock and animal hus-
bandry differ.
MATERIALS AND METHODS
Ethical approvals. Approval to obtain and sequence isolates from patients with bloodstream
infection in the United Kingdom and Ireland was obtained from the National Research Ethics Service
(reference 12/EE/0439) and the CUH Research and Development (R&D) Department (reference A092685).
Approval for bacterial isolation from wastewater and farms was obtained from the National Research
Ethics Service (reference 14/EE/1123), the Cambridge University Hospitals NHS Foundation Trust R&D
Department (reference A093285), and the Department of Veterinary Medicine, University of Cambridge
(study CR112).
Isolation of E. faecium strains from livestock, retail meat, and wastewater. A cross-sectional
survey was performed between August 2014 and April 2015 to isolate E. faecium strains from 20 livestock
farms (ten cattle and ten pig) in the East of England. The farms were chosen randomly from a pool of
farms served by veterinary surgeons at the University of Cambridge. Farm characteristics are shown in
Fig. S1C. Poultry reared at nine farms (four chicken and ﬁve turkey) in the East of England were sampled
at two abattoirs between February and April 2015. Farm details, sampling strategy, and processing of
samples are described in the Supplemental Methods. All samples were processed on the day of collection
and subjected to direct and enriched cultures.
Two cross-sectional surveys were performed between February and April 2015 to detect vancomycin-
resistant E. faecium isolates from retail meat purchased from high-street supermarkets. In the ﬁrst survey,
103 prepackaged meat samples (52 pork and 51 chicken), all of UK farm origin, were purchased from ﬁve
locations in the United Kingdom, including Cambridge (2 to 11 supermarket brands sampled per
location) and frozen at 20°C immediately after purchase. In the second survey, 97 products (16 beef,
30 chicken, 42 pork, 7 turkey, 1 pork/beef, and 1 venison) from multiple countries of origin were obtained
from 11 major supermarkets in the Cambridge area and tested within 24 h of purchase. Sample
processing is described in detail in the Supplemental Methods.
Collection of wastewater from 20 municipal wastewater treatment plants across the East of England
between June 2014 and January 2015 has been described previously (39). In brief, ten plants were
situated downstream of acute NHS Hospital Trusts, and ten plants were not connected to acute hospital
efﬂuent. Paired samples of untreated and treated wastewater were obtained from each plant. Sampling
strategy and sample processing are described in the Supplemental Methods.
E. faecium isolates associated with bloodstream infection. A total of 793 E. faecium genome
sequences reported previously (18, 23) were downloaded from the Wellcome Sanger Institute. Of these,
308 isolates were isolated at the Cambridge University Hospitals NHS Foundation Trust (CUH) diagnostic
laboratory, Cambridge (UK), and included the ﬁrst available isolate from all consecutive patients with
either vancomycin-resistant (n 200) or vancomycin-susceptible (n 93) E. faecium bloodstream infec-
tions between 2006 and 2012 (18). To provide national context, we included 474 isolates (roughly equal
numbers of VREfm and vancomycin-susceptible Enterococcus faecium [VSEfm]) from the British Society
for Antimicrobial Chemotherapy (BSAC) Bacteraemia Resistance Surveillance Programme (www.bsacsurv
.org) between 2001 to 2011 from 40 hospital diagnostic laboratories across the United Kingdom and
Ireland (23), and 11 isolates from the National Collection of Type Cultures (NCTC). Phenotypic suscep-
tibility to vancomycin was determined previously using the BSAC disc diffusion method (40) or the
VITEK2 system (bioMérieux, Marcy l’Etoile, France) with the AST-P607 card (18, 23). This demonstrated
that 445/793 isolates (56%) were resistant to vancomycin.
Sequencing and analysis of sequence data. DNA libraries were prepared according to the Illumina
protocol and sequenced on an Illumina HiSeq 2000 with 100-cycle paired-end runs. The new sequence
data generated by this study have been deposited in the European Nucleotide Archive (www.ebi.ac.uk/
ena) under the accession numbers provided in Table S2. All bacterial genomes used in the analysis
(782 human bloodstream, 11 NCTC, 383 wastewater, 253 livestock, and three meat) were assembled
using Velvet and annotated using Prokka. Multilocus sequence typing (MLST) was determined from
genome assemblies using MLST Check (41), with novel alleles and STs deposited in the pubMLST
database (https://pubmlst.org/efaecium/). Absence of the pstS gene in two isolates was conﬁrmed by a
second method based on read mapping (Short Read Sequence Typing for Bacterial Pathogens [SRST2])
(42). Pangenomes were estimated for the livestock and meat isolates alone and for the entire study
collection plus ten reference genomes using Roary, with a 90% identity (ID) cutoff and genes classed as
“core” if they were present in 99% of isolates. Maximum-likelihood trees were created using RAxML,
based on SNPs in the core genes. The livestock and meat phylogeny was based on 99,377 SNPs in
1,523 core genes (total of 12,393 genes); the livestock, meat, clinical, and wastewater phylogeny was
based on 95,115 SNPs in 1,166 core genes (total of 22,284 genes).
Isolates were clustered using Bayesian analysis of population structure (BAPS) (43) based on the core
genes of the study collection and reference genomes, described in more detail in the Supplemental
Methods. The resulting BAPS groups are clusters of related isolates based on Bayesian inference of the
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genetic structure of the population. The study collection was deduplicated for further analysis by
removing all isolates that were 0 to 2 SNPs from another isolate from the same location (same farm,
wastewater treatment plant, or hospital) based on SNPs in the core genes. All subsequent analyses were
performed on this deduplicated data set. For analysis within BAPS groups, clade A isolates were mapped
to a reference genome from the same BAPS group using SMALT, described further in the Supplemental
Methods. SNPs were identiﬁed within each BAPS group (or second-order BAPS groups for BAPS4), and
pairwise SNP differences between isolates were identiﬁed using an in-house script. A network ﬁle for the
livestock and wastewater isolates was created in R with cutoffs of seven and 35 SNPs used to deﬁne
relationships, and plotted in MicroReact. Principal component analysis was performed across the whole
deduplicated collection based on the accessory genes from Roary using R. Scoary (44) was used to
determine genes associated with speciﬁc reservoirs and was performed across the livestock and human
invasive collection. The presence of antibiotic, biocide, and metal resistance genes was determined using
Ariba with a 90% ID cutoff (45). Sequences of genes classed as present in Ariba were extracted from the
Ariba output. Further details are provided in the Supplemental Methods. Statistical analysis was per-
formed using Fisher’s exact test with a P value of 0.05.
DNA from one VREfm meat isolate was extracted using the phenol-chloroform method, sequenced
using the PacBio RS II instrument, and sequence data processed as previously described (18). Genomic
reads were mapped against this plasmid using SMALT, as above, and visualized using an in-house tool.
The sequence for this isolate is available in the European Nucleotide Archive under accession number
ERS1420638, with the plasmid containing vanA being contig 3.
Data availability. Accession numbers for the sequence data generated by this study are provided in
Table S2, with sequences deposited in the European Nucleotide Archive (www.ebi.ac.uk/ena).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.01780-18.
TEXT S1, DOCX ﬁle, 0.03 MB.
FIG S1, PDF ﬁle, 0.3 MB.
FIG S2, PDF ﬁle, 0.1 MB.
TABLE S1, XLSX ﬁle, 0.01 MB.
TABLE S2, XLSX ﬁle, 0.1 MB.
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